Friday, July 10, 2026

Drug profile · INN

birch bark extract

birch bark extract (FILSUVEZ) is a unknown.

EMA: approved Dermatologicals (D03) D03AX13
Patents linked 1
Pipeline programs 0
News articles 0
Drug details — birch bark extract
Class
Dermatologicals (D03)
Route
Patents
1
Programs
0
Data quality
0.83

Quick answer

birch bark extract (FILSUVEZ) is a unknown.

Key facts

INN birch bark extract
Brand FILSUVEZ
Mechanism Unknown
Therapeutic class Dermatologicals (D03)
ATC code D03AX13

Mechanism of action

Unknown

Approval history

Authority Status Date
EMA approved

Related & competitor drugs

  1. beremagene geperpavec Dermatologicals (D03)
  2. dupilumab Dermatologicals (D11)
  3. imiquimod Dermatologicals (D06)
  4. lebrikizumab Dermatologicals (D11)
  5. retapamulin Dermatologicals (D06)
  6. tacrolimus Dermatologicals (D11)

Related patents

  1. US 12268695

    Betulin-containing birch bark extracts and their formulation

    Expires Mon Apr 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is birch bark extract?

birch bark extract (FILSUVEZ) is a unknown.

What is the brand name for birch bark extract?

FILSUVEZ is a marketed brand name for birch bark extract. Check FDA Drugs@FDA for the current US label holder and prescribing information.